| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:503386623:1927 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:503386623:1927?format=raw |
LEADER: 01927cam a2200409 i 4500
001 3949666
005 20221027005018.0
008 900319s1976 ne a b 101 0 eng
010 $a 76025903
020 $a0444152229 (Elsevier)
035 $a(OCoLC)2347102
035 $a(OCoLC)ocm02347102
035 $a(CStRLIN)NYCM90-B618
035 $9AEJ8669HS
035 $a(NNC)3949666
035 $a3949666
040 $dNNC-M
050 00 $aRC685.C6$bI54 1975
060 0 $aW3 EX89 no. 388 1975$aWG300 I61 1975n
082 0 $a616.1/23/061
111 2 $aInternational Adalat® Symposium$n(3rd :$d1975 :$cRio de Janeiro, Brazil)
245 10 $aNew therapy of ischemic heart disease :$bproceedings of the symposium held at Rio de Janeiro, October 10-11, 1975 /$c3rd International Adalat® Symposium ; edited by Adib Domingos Jatene, Paul R. Lichtlen.
260 $aAmsterdam :$bExcerpta Medica ;$aNew York :$bSole distributors for the USA and Canada, Elsevier/North Holland Inc.,$c1976.
300 $axiii, 313 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aInternational congress series ;$vno. 388
504 $aIncludes bibliographical references.
650 0 $aCoronary heart disease$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2008101754
650 0 $aNifedipine$xTherapeutic use$vCongresses.
650 2 $aCoronary Disease$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D003327Q000188
650 2 $aPyridines$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D011725Q000627
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aJatene, Adib.$0http://id.loc.gov/authorities/names/n95921952
700 1 $aLichtlen, Paul R.$0http://id.loc.gov/authorities/names/n50050251
830 0 $aInternational congress series ;$vno. 388.$0http://id.loc.gov/authorities/names/n42029631
852 00 $boff,hsl$hRM666.N53$iIn8 1975